Cutaneous Oncology News

ORLANDO — Patients with localized high-risk cutaneous squamous cell carcinoma who received adjuvant radiation after clear margin surgery experienced decreased risk for local recurrence and nodal metastasis, according to study results.

ORLANDO — Among patients with skin of color, women were more likely to be diagnosed with melanoma compared with men, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

Clinical and genetic risk factors can help identify individuals at risk for immune checkpoint inhibitor-induced diabetes, according to results of a cohort study.

ORLANDO — A presentation at the American Society for Dermatologic Surgery Annual Meeting detailed new data that showcased the validity of the Merlin test in identifying sentinel lymph node biopsy status in high-risk patients with melanoma.

ORLANDO — A skin cancer diagnosis can be very overwhelming for a patient. Sharing informative materials about treatment options may ease their minds, according to a speaker at the American Society for Dermatologic Surgery Annual Meeting.

The melanoma 31-gene expression profile test can help physicians to better estimate risk for sentinel lymph nodes, possibly reducing the need for biopsies, according to a study.

The rates of melanoma incidence have significantly declined since approximately 2015 in patients aged younger than 50 years while mortality also dropped in those aged younger than 60, according to a Swedish study.

While Black patients are less likely to develop first melanoma than white patients, this group has a higher relative rate of secondary melanoma diagnosis, according to a study.

The FDA has approved the supplemental new drug application for Ameluz topical gel 10% to increase the maximal dosage from one to three tubes per treatment of actinic keratosis, according to a Biofrontera press release.

The first over-the-counter monograph order request tier 1 application for bemotrizinol, an active sunscreen ingredient, has been submitted to the FDA, dsm-firmenich announced in a press release.